Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Equine Myostatin (MSTN) ELISA Kit-Sandwich

Cat. No.EK1F149

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Equine Myostatin (MSTN) ELISA Kit-Sandwich is designed for the quantitative determination of Equine Myostatin (MSTN) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Equine MSTN.
Target Species Equine
Species Reactivity Equine
Detection Range 6.25-400 ng/mL
Sensitivity 2.84 ng/mL
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 210 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Growth Differentiation Factor 8 (GDF8), also known as myostatin, is a protein encoded by the equine gene MSTN. Myostatin is a myokine produced and released by myocytes (muscle cells). It acts on muscle cells to inhibit muscle growth. Essentially, myostatin is a negative regulator of skeletal and cardiac muscle. Research has shown that the variation in serum myostatin concentrations among horses is not influenced by age or sex.

Target/Biomarker Equine MSTN
Target Synonym GDF8; Growth Differentiation Factor 8
Gene ID 100033832
UniProt ID Q9GM97

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. O'Hara, V. et al. A highly prevalent SINE mutation in the myostatin (MSTN) gene promoter is associated with low circulating myostatin concentration in Thoroughbred racehorses. Scientific reports. 2021, 11: 7916.
Inquiry Basket